A case of nivolumab-associated colitis, which relapsed after mucosal healing and was then successfully treated with mesalazine

A case of nivolumab-associated colitis, which relapsed after mucosal healing and was then successfully treated with mesalazine

Currently, the number of patients treated with immune-checkpoint inhibitor involving nivolumab is increasing. Nevertheless, it causes various immune-related adverse events (irAEs). Here, we report the case of a patient who underwent long-term follow-up after suffering from nivolumab-associated colit...

Full description

Bibliographic Details
Main Authors: Hidezumi Kikuchi, Hirotake Sakuraba, Yui Akemoto, Yasuhisa Murai, Yukari Fukutoku, Taka Asari, Tetsuya Tatsuta, Keisuke Hasui, Hiroto Hiraga, Manabu Sawaya, Daisuke Chinda, Tatsuya Mikami, Masanori Tanaka, Shinsaku Fukuda
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Immunological Medicine
Subjects:
immune-related adverse events
relapse
fecal immunochemical test
fecal calprotectin
mesalazine
Online Access:http://dx.doi.org/10.1080/25785826.2019.1580477

Internet

http://dx.doi.org/10.1080/25785826.2019.1580477

Similar Items